Consolidated Condensed Statements of Operations (USD $) In Millions, except Per Share data, unless otherwise specified	3 Months Ended		6 Months Ended
	Apr. 28, 2013	Apr. 29, 2012	Apr. 28, 2013	Apr. 29, 2012
Income Statement [Abstract]
Net sales	$ 1,973	$ 2,541	$ 3,546	$ 4,730
Cost of products sold	1,165	1,530	2,156	2,933
Gross margin	808	1,011	1,390	1,797
Operating expenses:
Research, development and engineering	344	321	648	625
Selling, general and administrative	244	281	474	584
Impairment of goodwill and intangible assets (Note 8)	278	0	278	0
Restructuring charges and asset impairments (Note 10)	10	0	19	0
Total operating expenses	876	602	1,419	1,209
Income (loss) from operations	(68)	409	(29)	588
Impairments of strategic investments (Notes 3 and 4)	2	3	2	3
Interest and other expenses (Note 9)	24	23	48	47
Interest and other income, net	4	4	7	8
Income (loss) before income taxes	(90)	387	(72)	546
Provision for income taxes	39	98	23	140
Net income (loss)	$ (129)	$ 289	$ (95)	$ 406
Earnings (loss) per share:
Basic and diluted (in dollars per share)	$ (0.11)	$ 0.22	$ (0.08)	$ 0.31
Weighted average number of shares:
Basic (in shares)	1,203	1,289	1,200	1,294
Diluted (in shares)	1,203	1,301	1,200	1,305